In: Accounting
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:
1 |
Dec. 31, 20Y3 |
Dec. 31, 20Y2 |
|
2 |
Assets |
||
3 |
Cash |
$625,080.00 |
$586,430.00 |
4 |
Accounts receivable (net) |
228,260.00 |
209,470.00 |
5 |
Inventories |
641,070.00 |
616,400.00 |
6 |
Investments |
0.00 |
240,170.00 |
7 |
Land |
327,640.00 |
0.00 |
8 |
Equipment |
705,000.00 |
552,830.00 |
9 |
Accumulated depreciation-equipment |
(165,670.00) |
(148,610.00) |
10 |
Total assets |
$2,361,380.00 |
$2,056,690.00 |
11 |
Liabilities and Stockholders’ Equity |
||
12 |
Accounts payable (merchandise creditors) |
$425,090.00 |
$405,900.00 |
13 |
Accrued expenses payable (operating expenses) |
43,140.00 |
52,460.00 |
14 |
Dividends payable |
23,780.00 |
19,970.00 |
15 |
Common stock, $4 par |
147,000.00 |
96,000.00 |
16 |
Paid-in capital: Excess of issue price over par—common stock |
417,200.00 |
279,600.00 |
17 |
Retained earnings |
1,305,170.00 |
1,202,760.00 |
18 |
Total liabilities and stockholders’ equity |
$2,361,380.00 |
$2,056,690.00 |
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
A. | The investments were sold for $280,150 cash. |
B. | Equipment and land were acquired for cash. |
C. | There were no disposals of equipment during the year. |
D. | The common stock was issued for cash. |
E. | There was a $197,450 credit to Retained Earnings for net income. |
F. | There was a $95,040 debit to Retained Earnings for cash dividends declared. |
Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.
Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.
Livers Inc. |
Statement of Cash Flows |
1 |
Cash flows from operating activities: |
||
2 |
|||
3 |
Adjustments to reconcile net income to net cash flow from operating activities: |
||
4 |
|||
5 |
|||
6 |
Changes in current operating assets and liabilities: |
||
7 |
|||
8 |
|||
9 |
|||
10 |
|||
11 |
|||
12 |
|||
13 |
Cash flows from investing activities: |
||
14 |
|||
15 |
|||
16 |
|||
17 |
|||
18 |
|||
19 |
Cash flows from financing activities: |
||
20 |
|||
21 |
|||
22 |
|||
23 |
|||
24 |
Cash at the beginning of the year |
||
25 |
Cash at the end of the year |
1.
Livers Inc | |||
Partial Statement of Cash Flows | |||
Cash flows from operating activities | |||
Net Income | $ 197,450 | ||
Adjustments to reconcile net income to : | |||
Depreciation expenses | $ 17,060 | 165670-148610 | |
Gain on sale of investment | $ (39,980) | 240170-280150 | |
Increase in accounts receivable | $ (18,790) | 209470-228260 | |
Increase in inventory | $ (24,670) | 616400-641070 | |
Increase in accounts payable | $ 19,190 | 425090-405900 | |
Decrease in accrued expense payable | $ (9,320) | 43140-52460 | |
Net cash flow from operating activities | $ 140,940 |
2.
Livers Inc | |||
Statement of Cash Flows | |||
Net cash flow from operating activities | $ 140,940 | ||
Cash flows from investing activities | |||
Proceeds from Sale of investments | $ 280,150 | ||
Cash paid for purchase of Equipment | $ (152,170) | 552830-705000 | |
Cash paid for purchase of Land | $ (327,640) | ||
Net cash used by investing activities | $ (199,660) | ||
Cash flows from financing activities | |||
Proceeds from issuance of common stock | $ 188,600 | 147000-96000+417200-279600 | |
Cash paid for dividends | $ (91,230) | 23780-19970-95040 | |
Net cash provided by financing activities | $ 97,370 | ||
Net Decrease in cash and cash equivalents | $ 38,650 | ||
Cash and cash equivalents at beginning of period | $ 586,430 | ||
Cash and cash equivalents at end of period | $ 625,080 |